Status:
COMPLETED
Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy
Lead Sponsor:
AstraZeneca
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
This is an open label, non-interventional quality of life analysis for Zoladex treated prostate cancer patients by investigator's questionnaire
Eligibility Criteria
Inclusion
- Provision of informed consent
- Early or locally-advanced prostate cancer patients on androgen deprivation therapy
- Investigators are requested to recruit patients only with at least 1 month prior Zoladex treatment.
Exclusion
- Allergy to substance of medication
- Prostate cancer patients with advanced disease
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
1646 Patients enrolled
Trial Details
Trial ID
NCT00692874
Start Date
June 1 2008
End Date
September 1 2010
Last Update
December 10 2010
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Baja, Hungary
2
Research Site
Békés, Hungary
3
Research Site
Békéscsaba, Hungary
4
Research Site
Budapest, Hungary